Answers are grounded in this paper and cite their sources.
Many p53-defective tumors retain activity of the apoptosome, which is therefore a potential target for cancer chemotherapy. Inhibition of ACS may be a novel strategy to induce the death of p53-defective tumor cells.
No takes yet. Share an insight, caveat, or question.
Mashima et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: